GTN
The AI engine Fit Assessment
BetaGTN effectively utilizes machine learning and pattern discovery to innovate drug discovery, expanding therapeutics and optimizing the process.
Blurb
GTN innovates a quantum machine learning technology to transform drug discovery.
HQ Location
London (United Kingdom)
Founded
2017
Employees
11 - 50
Total funding raised
$2.84M
Funding Status
Seed, November 1, 2018
Subspaces
- Drug Discovery Optimization
Provider of a drug discovery platform intended to transform drug discovery through interdisciplinary innovation. The company's platform combines quantum physics and machine learning algorithms to transform the search and discovery of patient-centered drugs, enabling researchers to discover new medicines that are more effective and affordable while accelerating the development process.